Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.064 | 0.7 |